EIR Novartis Pharmaceuticals Feb 2000

Douglas Kovacs FDA$595.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - East Hanover, NJ, United States facility and issued inspectional observation (via FDA 483) on 23 Feb 2000.

Product details

  • Category:
  • Inspection end: 23 Feb 2000
  • Location: East Hanover, United States
  • FEI: 2210396
Add To Cart